Cargando…

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) after SARS‐CoV‐2 vaccination: Two cases from Germany with unusual presentation

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare clinical condition that has emerged during the mass immunization against SARS‐CoV‐2. Reports indicate that VITT may also be induced by other vaccines, such as the human papillomavirus vaccine, or occur independently of vaccination....

Descripción completa

Detalles Bibliográficos
Autores principales:	Edmonds, Rhea, Schönborn, Linda, Habben, Sunke, Paparoupa, Maria, Greinacher, Andreas, Schuppert, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859986/ https://www.ncbi.nlm.nih.gov/pubmed/36698527 http://dx.doi.org/10.1002/ccr3.6883

Ejemplares similares

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)—Insights from Clinical Cases, In Vitro Studies and Murine Models
por: Dabbiru, Venkata A. S., et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022)

Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
por: Noyé, Mickaël, et al.
Publicado: (2022)

Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
por: John, Christy V., et al.
Publicado: (2022)

Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022)

Decline in Pathogenic Antibodies over Time in VITT
por: Schönborn, Linda, et al.
Publicado: (2021)

Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway
por: Salih, Farid, et al.
Publicado: (2022)

Persistence of Ad26.COV2.S‐associated vaccine‐induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies
por: Kanack, Adam J., et al.
Publicado: (2022)

Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
por: Thiele, Thomas, et al.
Publicado: (2021)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

Renal Vein Thrombosis and Pulmonary Embolism Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT)
por: Cliff-Patel, Nikita, et al.
Publicado: (2021)

A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis
por: Mendes-de-Almeida, Daniela P., et al.
Publicado: (2023)

Audit of pathology requesting behaviour in the setting of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Maclean, Marsali, et al.
Publicado: (2022)

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
por: Lavin, Michelle, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)

SARS-CoV-2 Infection in Patients with a History of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Microsurgical complication associated with vaccine-induced immune thrombotic thrombocytopenia (VITT): A case report
por: Hung, Chen-Ting, et al.
Publicado: (2023)

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection
por: McGonagle, Dennis, et al.
Publicado: (2021)

AZD-1222: Vaccine-induced thrombosis with thrombocytopenia (VITT) and arterial and venous thrombotic stroke : case report
Publicado: (2022)

Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
por: Günther, Albrecht, et al.
Publicado: (2021)

COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes
por: Allas, Gewil Daniella Olipas, et al.
Publicado: (2022)

Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown
por: Sunder, Ashok, et al.
Publicado: (2022)

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report
por: Mancuso, Michelangelo, et al.
Publicado: (2022)

Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
por: Kotwal, Jyoti, et al.
Publicado: (2023)

Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia—VITT
por: Gessler, Florian, et al.
Publicado: (2021)

COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) and Cerebral Venous Sinus Thrombosis (CVST)- Lessons for India
por: Khan, Erum, et al.
Publicado: (2022)

Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
por: John, Christy V., et al.
Publicado: (2023)

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
por: Handtke, Stefan, et al.
Publicado: (2021)

Most cases of Thrombosis and Thrombocytopenia Syndrome (TTS) post ChAdOx-1 nCov-19 are Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US
por: Rodriguez, Elsa V. C., et al.
Publicado: (2021)

Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
por: Myllylahti, Lasse, et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
por: Liam, Christopher Chin Keong, et al.
Publicado: (2022)

Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review
por: Warkentin, Theodore E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q19kke6l0d25b260iggb5jiqpl